411 related articles for article (PubMed ID: 20488911)
21. Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
Yebyo HG; Aschmann HE; Puhan MA
Ann Intern Med; 2019 Jan; 170(1):1-10. PubMed ID: 30508425
[TBL] [Abstract][Full Text] [Related]
22. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
[TBL] [Abstract][Full Text] [Related]
23. Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study.
Liu JC; Hao WR; Hsu YP; Sung LC; Kao PF; Lin CF; Wu AT; Yuan KS; Wu SY
Oncotarget; 2016 Oct; 7(40):65270-65283. PubMed ID: 27542242
[TBL] [Abstract][Full Text] [Related]
24. One-year survival and admission to hospital for cardiovascular events among older residents of long-term care facilities who were prescribed intensive- and moderate-dose statins.
Campitelli MA; Maxwell CJ; Maclagan LC; Ko DT; Bell CM; Jeffs L; Morris AM; Lapane KL; Daneman N; Bronskill SE
CMAJ; 2019 Jan; 191(2):E32-E39. PubMed ID: 30642823
[TBL] [Abstract][Full Text] [Related]
25. The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care.
García-Rodríguez LA; Massó-González EL; Wallander MA; Johansson S
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):943-52. PubMed ID: 18425988
[TBL] [Abstract][Full Text] [Related]
26. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database.
Hippisley-Cox J; Coupland C; Robson J; Brindle P
BMJ; 2010 Dec; 341():c6624. PubMed ID: 21148212
[TBL] [Abstract][Full Text] [Related]
27. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
Ridker PM; MacFadyen JG; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):616-23. PubMed ID: 20031900
[TBL] [Abstract][Full Text] [Related]
28. Patients who discontinued statin treatment: a protocol for cohort study using primary care data.
Vinogradova Y; Coupland C; Brindle P; Hippisley-Cox J
BMJ Open; 2015 Oct; 5(10):e008701. PubMed ID: 26493458
[TBL] [Abstract][Full Text] [Related]
29. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.
Dormuth CR; Hemmelgarn BR; Paterson JM; James MT; Teare GF; Raymond CB; Lafrance JP; Levy A; Garg AX; Ernst P;
BMJ; 2013 Mar; 346():f880. PubMed ID: 23511950
[TBL] [Abstract][Full Text] [Related]
30. [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].
Karie S; Launay-Vacher V; Deray G; Isnard-Bagnis C
Presse Med; 2006 Feb; 35(2 Pt 1):219-29. PubMed ID: 16493350
[TBL] [Abstract][Full Text] [Related]
31. Results of a safety initiative for patients on concomitant amiodarone and simvastatin therapy in a Veterans Affairs medical center.
Karimi S; Hough A; Beckey C; Parra D
J Manag Care Pharm; 2010 Sep; 16(7):472-81. PubMed ID: 20726676
[TBL] [Abstract][Full Text] [Related]
32. Age, sex and practice variations in the use of statins in general practice in England and Wales.
Majeed A; Moser K; Maxwell R
J Public Health Med; 2000 Sep; 22(3):275-9. PubMed ID: 11077897
[TBL] [Abstract][Full Text] [Related]
33. Differential impact of statin on new-onset diabetes in different age groups: a population-based case-control study in women from an asian country.
Chen CW; Chen TC; Huang KY; Chou P; Chen PF; Lee CC
PLoS One; 2013; 8(8):e71817. PubMed ID: 23951249
[TBL] [Abstract][Full Text] [Related]
34. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
35. The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study.
Mueller AM; Liakoni E; Schneider C; Burkard T; Jick SS; Krähenbühl S; Meier CR; Spoendlin J
J Gen Intern Med; 2021 Sep; 36(9):2639-2647. PubMed ID: 33751411
[TBL] [Abstract][Full Text] [Related]
36. Effects of Statin Therapy and Dose on Cardiovascular and Limb Outcomes in Peripheral Arterial Disease: A Systematic Review and Meta-analysis.
Sofat S; Chen X; Chowdhury MM; Coughlin PA
Eur J Vasc Endovasc Surg; 2021 Sep; 62(3):450-461. PubMed ID: 34389230
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.
Zhou Z; Rahme E; Abrahamowicz M; Tu JV; Eisenberg MJ; Humphries K; Austin PC; Pilote L
CMAJ; 2005 Apr; 172(9):1187-94. PubMed ID: 15851712
[TBL] [Abstract][Full Text] [Related]
38. Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
Naci H; Brugts J; Ades T
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):390-9. PubMed ID: 23838105
[TBL] [Abstract][Full Text] [Related]
39. A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.
Hoffman KB; Kraus C; Dimbil M; Golomb BA
PLoS One; 2012; 7(8):e42866. PubMed ID: 22936996
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2011 Aug; 343():d4656. PubMed ID: 21846713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
